The short version
- In the STEP 1 trial of 1,961 adults, once-weekly semaglutide 2.4 mg produced a mean body weight change of -14.9% over 68 weeks versus -2.4% on placebo, equal to -15.3 kg against -2.6 kg.
- No dietary supplement has produced a comparable result; the best-conducted supplement trials in a 2021 systematic review reported between-group differences of 0.3 kg to 4.93 kg.
- Endogenous GLP-1 is degraded within minutes: 30 minutes after a subcutaneous dose in healthy subjects, 78.4% of the rise in measurable peptide was already the inactive truncated metabolite.
- LUVO's FLUX is a digestive comfort and nutrient-gap formula for people already eating less; it contains no appetite suppressant and does not act on the GLP-1 receptor.
- A 2023 poison control case series described three adverse events from compounded semaglutide, two of them ten-fold self-administered dosing errors causing days of nausea, vomiting and abdominal pain.
Let us get the awkward part out of the way. We sell a product called FLUX, filed under GLP-1 support. It does not work like semaglutide. It does not work a little bit like semaglutide. It is not in the same category of thing, and this article exists so that nobody buys it believing otherwise.
What the drug actually did
STEP 1, published in the New England Journal of Medicine in 2021, randomised 1,961 adults with a BMI of 30 or above — or 27 with a weight-related condition — to 68 weeks of once-weekly semaglutide at 2.4 mg or placebo, both alongside lifestyle intervention. Mean change in body weight was -14.9% on semaglutide against -2.4% on placebo: -15.3 kg versus -2.6 kg. Half the treated group, 50.5%, lost at least 15% of their body weight. In the placebo group, 4.9% did.
Now set that beside the supplement literature. The most thorough review of the weight-loss shelf found 315 randomised trials, judged 52 of them adequately conducted, and reported that the sixteen positive ones produced differences of 0.3 kg to 4.93 kg. The best supplement result anyone has published is roughly a third of what the drug's average participant got, in trials a fraction as rigorous.
That is the honest comparison, and no amount of ingredient sourcing closes it.
Why "boosts your natural GLP-1" is a weaker sentence than it sounds
Your gut releases GLP-1 after you eat. That is real physiology. The problem is what happens next: the peptide is clipped apart almost immediately. In a 1995 study in Diabetes, researchers gave GLP-1 to healthy subjects and to people with type 2 diabetes and measured what was still intact half an hour later. Thirty minutes after a subcutaneous dose, the inactive N-terminally truncated metabolite accounted for 78.4% of the rise in measurable peptide in the healthy subjects, and 88.5% in the diabetic patients. When GLP-1 was infused into a vein, intact peptide made up only about 20% of the increase in healthy subjects.
The entire pharmaceutical achievement of the GLP-1 drug class is engineering around that. Semaglutide is modified specifically to resist the enzyme that does the clipping, which is why one injection lasts a week. A capsule that nudges your own secretion upward for an hour after dinner is not a small version of that. It is a different event.
Some botanicals do plausibly touch the pathway. There is a 2024 review in Archives of Physiology and Biochemistry mapping how berberine may induce GLP-1 secretion, largely via the gut microbiome and short-chain fatty acids. Read what it is: a pathway review, drawing together mechanism papers. It is not a body-weight trial, and the authors do not present it as one. A mechanism is a hypothesis about why something might work. It is not evidence that it did.
What FLUX is, in plain words
FLUX is a digestive-comfort and nutrient-gap formula for people who are already eating less. Ginger, peppermint, digestive enzymes and probiotics for the smaller meal you actually ate. Methylcobalamin B12, 5-MTHF folate, P5P B6, zinc, iron and biotin for the vitamins that disappear when portions shrink, in the forms your body uses without a conversion step.
Nothing in it is there to suppress your appetite. It does not slow gastric emptying the way the drug class does, it does not act on a GLP-1 receptor, and it will not produce a number on a scale. If you are eating less — on a plan you built with your doctor, because you are on a prescription, or because your body changed — it is nutritional support for that situation. If you are eating normally and want to stop, this is not the product, and we would rather say so than take the order.
The thing we most want you to avoid
Grey-market injectables. A 2023 case series from a US poison control centre described three people who took compounded semaglutide obtained from compounding pharmacies and an aesthetic spa. Two of them self-administered ten-fold overdoses. All three had days of nausea, vomiting and abdominal pain; one needed a healthcare visit and intravenous fluids. One had been handed a vial and syringes with no counselling, and one was dosing in millilitres and units rather than milligrams.
If GLP-1 medication is right for you, it is right for you through a prescriber who titrates it, monitors it and answers the phone. That is a medical decision and it belongs entirely with your doctor. It is not something to source sideways because the wait is long or the price is high.
What we'd actually tell you
If you want appetite change, the two levers with real published support are food composition and medical care, in that order. Protein's satiety effect is the reproducible dietary one. Everything else in the supplement aisle labelled for appetite is either caffeine, fibre, or a name borrowed from a drug.
And if you are on a GLP-1 medication already, the useful conversation is not which supplement to add. It is protein intake, resistance training to protect lean mass, and whether your bloodwork is holding up on fewer calories — three things worth raising with your prescriber at your next appointment.
Good questions
Is there a natural alternative to Ozempic?
No. Semaglutide produced a 14.9% mean body weight reduction over 68 weeks in a 1,961-person trial, and nothing sold as a supplement has produced anything within reach of that. Products marketed as natural GLP-1 alternatives are named after a mechanism, not measured against the drug. If a GLP-1 medication is appropriate for you, that is a prescriber's decision.
What does FLUX actually do, then?
It supports digestive comfort and covers nutrient bases when you are eating less. Ginger, peppermint, enzymes and probiotics for the meal itself; methylated B12 and folate, P5P B6, zinc, iron and biotin for the vitamins that shrink along with portions. It does not touch appetite, and if appetite is what you want changed, it is the wrong purchase.
Can I take a GLP-1 support supplement instead of the injection?
No, and treating it as a substitute is the one mistake worth avoiding here. The drug class works because it resists the enzyme that destroys natural GLP-1 within minutes, which is an engineering achievement a capsule does not reproduce. If cost or access is the barrier, that is a conversation with your prescriber and insurer rather than a supplement problem.
Is berberine a GLP-1 supplement?
Not in any useful sense. There is a published pathway review describing how berberine might stimulate GLP-1 secretion through the gut microbiome, but that is mechanistic literature rather than weight-loss evidence. Berberine has its own modest, separately measured effects on glucose and lipids in people already diagnosed with something. Borrowing the GLP-1 label for it oversells both.
I am already on a GLP-1 medication. Do I need supplements?
Possibly, but ask your prescriber rather than a product page. Eating substantially less makes it harder to hit protein, B12, iron and folate, and that is a genuine nutritional gap worth checking with bloodwork. What you should not do is add anything that also affects blood glucose without telling the person managing your dose.
Should I buy compounded semaglutide online?
We would strongly advise against it. A poison control case series documented three adverse events, two involving ten-fold overdoses, with patients handed vials and syringes and no counselling on how to measure a dose. Prefilled manufactured pens exist precisely to make that mistake hard. This is a prescription medication and it needs a prescriber attached.
Sources
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med, 2021. View study
- Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Holst JJ. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes, 1995. View study
- Batsis JA, Apolzan JW, Bagley PJ, et al. A Systematic Review of Dietary Supplements and Alternative Therapies for Weight Loss. Obesity (Silver Spring), 2021. View study
- Araj-Khodaei M, Ayati MH, Azizi Zeinalhajlou A, et al. Berberine-induced glucagon-like peptide-1 and its mechanism for controlling type 2 diabetes mellitus: a comprehensive pathway review. Arch Physiol Biochem, 2024. View study
- Lambson JE, Flegal SC, Johnson AR. Administration errors of compounded semaglutide reported to a poison control center-Case series. J Am Pharm Assoc (2003), 2023. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
